Results 211 to 220 of about 266,382 (322)

Analysis of the human KCNH2(HERG) gene: Identification and characterization of a novel mutation Y667X associated with long QT syndrome and a non-pathological 9 bp insertion Communicated by: Mark H. Paalman Online Citation: Human Mutation, Mutation in Brief #325 (2000) Online http://journals.wiley.com/1059-7794/pdf/mutation/325.pdf [PDF]

, 2000
Aimée Paulussen, Ping Yang, Menelas N. Pangalos, Peter Verhasselt, Roger Marrannes, Christel Verfaille, Ine Vandenberk, Raf Crabbe, Frank Konings, Walter Luyten, Martin Armstrong   +10 more
openalex   +1 more source

Clinical characteristics and gene analysis of long QT syndrome in 15 children. [PDF]

Front Pediatr
Yiwei L, Peiwen G, Tiewei L, Huichao S.
europepmc   +1 more source

Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study

Journal of Sleep Research, Volume 34, Issue 3, June 2025.
Summary Obstructive sleep apnea (OSA) syndrome commonly leads to excessive daytime sleepiness (EDS). Pitolisant, a selective histamine‐3 receptor antagonist, is efficacious at doses up to 20 mg once daily in OSA treated or not with continuous positive airway pressure (CPAP).
Yves Dauvilliers, Sonya Elizabeth Craig, Maria R. Bonsignore, Ferran Barbé, Johan Verbraecken, Jerryl Asin, Ognian Georgiev, Rumen Tiholov, Christian Caussé, Jeanne‐Marie Lecomte, Jean‐Charles Schwartz, Philippe Lehert, Winfried Randerath, Jean‐Louis Pépin, on behalf of the HAROSA III Study Group, Dejan Dokic, Hristo Metev, Iliev Kartev, Zdravka Karamyan, Ventsislav Nozharov, Daniel Petkov   +20 more
wiley   +1 more source

Arrhythomogenic substrate for cardiomyopathies: Arrhythmogenic right ventricular cardiomyopathy/dysplasia and idiopathic long QT syndrome.

, 1999
Sachio Kawai
openalex   +2 more sources

Phase 2 Early Afterdepolarization as a Trigger of Polymorphic Ventricular Tachycardia in Acquired Long-QT Syndrome [PDF]

, 2001
Gan‐Xin Yan, Ying Wu, Tengxian Liu, Jixin Wang, Roger A. Marinchak, Peter R. Kowey   +5 more
openalex   +1 more source

Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model

European Heart Journal, 2018
A. Mehta, C. Ramachandra, Pritpal Singh, A. Chitre, Chong Hui Lua, M. Mura, L. Crotti, P. Wong, P. Schwartz, M. Gnecchi, W. Shim   +10 more
semanticscholar   +1 more source

Cardiac Vagal Control and Emotional Awareness Associated With Pain Among Breast Cancer Survivors

Psychophysiology, Volume 62, Issue 6, June 2025.
ABSTRACT Pain is the most common symptom reported by breast cancer survivors (BCS), and it significantly affects their quality of life. Higher vagally mediated heart rate variability (vmHRV) is associated with higher emotional awareness (EA) and lower pain.
Keren Harel, Johanna Czamanski‐Cohen, Miri Cohen, Richard D. Lane, John J. B. Allen, Opher Caspi, Karen L. Weihs   +6 more
wiley   +1 more source

Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome

Cell, 2017
Ji Sun, R. MacKinnon
semanticscholar   +1 more source

Managing long QT syndrome patients, cooking, and common sense. [PDF]

Eur Heart J Suppl
Schwartz PJ, Dagradi F, Giovenzana FLF, Cerea P.   +3 more
europepmc   +1 more source

Inherited Brugada and Long QT-3 Syndrome Mutations of a Single Residue of the Cardiac Sodium Channel Confer Distinct Channel and Clinical Phenotypes [PDF]

, 2001
Ilaria Rivolta, Hugues Abriel, Michihiro Tateyama, Huajun Liu, Mirella Memmi, Panos Vardas, Carlo Napolitano, Silvia G. Priori, Robert S. Kass   +8 more
openalex   +1 more source